August 21, 2017 4:31 AM ET


Company Overview of Aegera Therapeutics, Inc.

Company Overview

Aegera Therapeutics, Inc. is a clinical-stage biotechnology company that develops therapeutics primarily to address oncology and immuno-inflammation. The company focuses on developing HGS1029, a small molecule pan-IAP inhibitor for the treatment of a range of cancers; and AEG35156, a second generation antisense oligonucleotide that targets XIAP and is designed to lower the apoptotic threshold of cancer cells. It also focuses on various preclinical stage programs in the areas of oncology, autoimmune/inflammatory, solid tumors, fungal infections, and central nervous system diseases that include small molecule Bruton's tyrosine kinase inhibitors, inhibitor of apoptosis proteins, FMS inhibitors,...

810 chemin du Golf

Montreal, QC H3E 1A8


Founded in 1997





Key Executives for Aegera Therapeutics, Inc.

Scientific Founder
Scientific Founder
Scientific Founder
Scientific Founder
Scientific Founder
Compensation as of Fiscal Year 2017.

Similar Private Companies By Industry

Company Name Region
2007262 Ontario, Inc. Americas
2056273 Ontario, Inc. Americas
AB BioPharma Inc. Americas
AbCelex Technologies Inc. Americas
AbCellera Biologics Inc. Americas

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States
Bertelsmann AG Europe
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Aegera Therapeutics, Inc., please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at